These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 15969861)

  • 1. Epoetin alfa offers clinically significant improvements in the quality of life of anaemic cancer patients.
    Curr Med Res Opin; 2005; 21 Suppl 2():S12-5. PubMed ID: 15969861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treating anaemia with epoetin alfa is associated with improvements in quality of life in cancer patients receiving chemotherapy.
    Curr Med Res Opin; 2005; 21 Suppl 2():S9-11. PubMed ID: 15969860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvements in quality of life associated with epoetin alfa treatment are clinically, as well as statistically, significant.
    Curr Med Res Opin; 2005; 21 Suppl 2():S3-5. PubMed ID: 15969858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Intervention with epoetin alfa during platinum-based chemotherapy: an analysis of quality-of-life results of a multicenter, randomized, controlled trial compared with population normative data.
    Savonije JH; van Groeningen CJ; Wormhoudt LW; Giaccone G
    Oncologist; 2006 Feb; 11(2):197-205. PubMed ID: 16476840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antianemic effect of once weekly regimen of epoetin alfa 40,000 units in anemic cancer patients receiving chemotherapy.
    Voravud N; Sriuranpong V; Suwanrusme H
    J Med Assoc Thai; 2007 Jun; 90(6):1082-8. PubMed ID: 17624200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits of epoetin alfa for cancer patients' quality of life are confirmed after modelling to account for missing data.
    Curr Med Res Opin; 2005; 21 Suppl 2():S6-8. PubMed ID: 15969859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of the effects of epoetin alfa treatment on quality of life in anaemic cancer patients.
    Curr Med Res Opin; 2005; 21 Suppl 2():S16-8. PubMed ID: 15969862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy.
    Witzig TE; Silberstein PT; Loprinzi CL; Sloan JA; Novotny PJ; Mailliard JA; Rowland KM; Alberts SR; Krook JE; Levitt R; Morton RF
    J Clin Oncol; 2005 Apr; 23(12):2606-17. PubMed ID: 15452187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epoetin alfa treatment results in clinically significant improvements in quality of life in anemic cancer patients when referenced to the general population.
    Cella D; Zagari MJ; Vandoros C; Gagnon DD; Hurtz HJ; Nortier JW
    J Clin Oncol; 2003 Jan; 21(2):366-73. PubMed ID: 12525531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical benefits of once-weekly epoetin alfa in anemic patients with colorectal cancer receiving chemotherapy.
    Chu E; Einhorn LH; Lefebvre P
    J Support Oncol; 2006 May; 4(5):243-50. PubMed ID: 16724648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early intervention with epoetin alfa during platinum-based chemotherapy: an analysis of the results of a multicenter, randomized, controlled trial based on initial hemoglobin level.
    Savonije JH; van Groeningen CJ; Wormhoudt LW; Giaccone G
    Oncologist; 2006 Feb; 11(2):206-16. PubMed ID: 16476841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality-of-life and health benefits of early treatment of mild anemia: a randomized trial of epoetin alfa in patients receiving chemotherapy for hematologic malignancies.
    Straus DJ; Testa MA; Sarokhan BJ; Czuczman MS; Tulpule A; Turner RR; Riggs SA
    Cancer; 2006 Oct; 107(8):1909-17. PubMed ID: 16977654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic anemia and fatigue in elderly patients: results of a randomized, double-blind, placebo-controlled, crossover exploratory study with epoetin alfa.
    Agnihotri P; Telfer M; Butt Z; Jella A; Cella D; Kozma CM; Ahuja M; Riaz S; Akamah J
    J Am Geriatr Soc; 2007 Oct; 55(10):1557-65. PubMed ID: 17697104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-treatment erythropoietin levels cannot be used to predict individual response to epoetin alfa in anaemic cancer patients.
    Curr Med Res Opin; 2005; 21 Suppl 2():S19-21. PubMed ID: 15969863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes and predicting response in anaemic chemotherapy patients treated with epoetin alfa. A multicentre, 4-month, open-label study in Australia and New Zealand.
    Bell D; Grimes D; Gurney H; Dalley D; Blackwell T; Fox R; Jeffery M
    Intern Med J; 2008 Oct; 38(10):751-7. PubMed ID: 19143877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anaemia management with epoetin alfa in lung cancer patients in The Netherlands.
    Biesma B; van de Werf PR; Melissant CF; Brok RG
    Lung Cancer; 2007 Oct; 58(1):104-11. PubMed ID: 17601632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, double-blind, placebo-controlled trial of erythropoietin in non-small-cell lung cancer with disease-related anemia.
    Wright JR; Ung YC; Julian JA; Pritchard KI; Whelan TJ; Smith C; Szechtman B; Roa W; Mulroy L; Rudinskas L; Gagnon B; Okawara GS; Levine MN
    J Clin Oncol; 2007 Mar; 25(9):1027-32. PubMed ID: 17312332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of epoetin supplemented with oral iron in patients with solid malignancies and chronic anemia not receiving anticancer treatment.
    Mystakidou K; Kalaidopoulou O; Katsouda E; Parpa E; Kouskouni E; Chondros C; Tsiatas ML; Vlahos L
    Anticancer Res; 2005; 25(5):3495-500. PubMed ID: 16101168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical benefits of epoetin alfa (Eprex) 10,000 units subcutaneously thrice weekly in Thai cancer patients with anemia receiving chemotherapy.
    Voravud N; Sriuranpong V
    J Med Assoc Thai; 2005 May; 88(5):607-12. PubMed ID: 16149676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of epoetin alpha therapy on cognitive function in anaemic patients with solid tumours undergoing chemotherapy.
    Iconomou G; Koutras A; Karaivazoglou K; Kalliolias GD; Assimakopoulos K; Argyriou AA; Ifanti A; Kalofonos HP
    Eur J Cancer Care (Engl); 2008 Nov; 17(6):535-41. PubMed ID: 18707621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.